Duska Petranovic

Rijeka, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 11, 2026

Development of a Health-Related Quality of Life Tool for Adolescents and Young Adults With Cancer.

Development of a Health-Related Quality of Life Tool for Adolescents and Young Adults With Cancer.

Journal: JAMA network open

Published: February 03, 2026

Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial.

Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial.

Journal: The Lancet. Oncology

Published: June 20, 2025

Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire.

Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 12, 2024

International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.

International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.

Journal: Blood advances

Published: May 30, 2023

Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA.

Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA.

Journal: HemaSphere

Published: February 17, 2023

International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).

International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).

Journal: Cancer

Published: January 24, 2023

International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.

International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.

Journal: British journal of haematology

Published: November 16, 2021

Developing Symptom Lists for People with Cancer Treated with Targeted Therapies.

Developing Symptom Lists for People with Cancer Treated with Targeted Therapies.

Journal: Targeted oncology

Published: November 09, 2020

Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: August 07, 2020

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity.

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity.

Journal: International journal of hematology

Published: May 08, 2020

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index.

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index.

Journal: Leukemia

Published: November 22, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026